Stock 3649 FINDEX INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials FINDEX Inc.

Equities

3649

JP3801450002

Advanced Medical Equipment & Technology

Market Closed - Japan Exchange
Other stock markets
 07:00:00 14/05/2024 BST 		5-day change 1st Jan Change
1,022 JPY -0.20% Intraday chart for FINDEX Inc. -1.64% -0.78%
04-15 Findex Disposes 10,855 Shares Worth 11 Million Yen as Restricted Stock Compensation MT
03-28 Findex to Allot Treasury Shares Worth 12 Million Yen to Directors, Executive Officers MT

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 13,770 34,665 29,727 25,765 12,656 26,416
Enterprise Value (EV) 1 12,959 32,758 27,626 23,614 10,243 23,723
P/E ratio 35.2 x 69.5 x 69.1 x 40.5 x 17.5 x 24.9 x
Yield 1.39% 0.59% 0.69% - 1.92% 1.26%
Capitalization / Revenue 3.82 x 8.1 x 7.42 x 5.19 x 2.79 x 5.09 x
EV / Revenue 3.6 x 7.65 x 6.9 x 4.75 x 2.26 x 4.57 x
EV / EBITDA 13 x 28 x 27.2 x 19.2 x 7.98 x 13.5 x
EV / FCF 59.5 x 26 x 115 x 59.2 x 40.6 x 55.2 x
FCF Yield 1.68% 3.85% 0.87% 1.69% 2.46% 1.81%
Price to Book 5.41 x 12.2 x 9.68 x 7.34 x 3.13 x 5.46 x
Nbr of stocks (in thousands) 25,596 25,602 25,604 25,612 25,620 25,647
Reference price 2 538.0 1,354 1,161 1,006 494.0 1,030
Announcement Date 28/03/19 30/03/20 29/03/21 30/03/22 29/03/23 28/03/24
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 3,603 4,281 4,004 4,968 4,541 5,191
EBITDA 1 999 1,168 1,016 1,227 1,283 1,753
EBIT 1 593 743 636 920 1,029 1,496
Operating Margin 16.46% 17.36% 15.88% 18.52% 22.66% 28.82%
Earnings before Tax (EBT) 1 593 743 643 944 1,059 1,524
Net income 1 398 499 430 636 722 1,059
Net margin 11.05% 11.66% 10.74% 12.8% 15.9% 20.4%
EPS 2 15.30 19.49 16.79 24.84 28.18 41.31
Free Cash Flow 1 217.6 1,260 239.5 399 252.1 430
FCF margin 6.04% 29.44% 5.98% 8.03% 5.55% 8.28%
FCF Conversion (EBITDA) 21.78% 107.91% 23.57% 32.52% 19.65% 24.53%
FCF Conversion (Net income) 54.68% 252.58% 55.7% 62.74% 34.92% 40.6%
Dividend per Share 2 7.500 8.000 8.000 - 9.500 13.00
Announcement Date 28/03/19 30/03/20 29/03/21 30/03/22 29/03/23 28/03/24
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2020 S1 2021 S1 2021 Q3 2021 Q4 2021 S2 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2022 S2 2023 Q1 2023 Q2 2023 S1 2023 Q3
Net sales 1 2,260 2,405 1,108 1,455 2,563 1,264 969.1 2,234 766 1,541 2,307 1,251 997.4 2,249 1,225
EBITDA - - - - - - - - - - - - - - -
EBIT 1 552 488 215 217 432 370 85.25 455.7 33 539.3 572.3 288 109 397.3 399
Operating Margin 24.42% 20.29% 19.4% 14.91% 16.86% 29.27% 8.8% 20.4% 4.31% 34.99% 24.8% 23.02% 10.93% 17.66% 32.57%
Earnings before Tax (EBT) 1 555 505 216 223 439 381 99.92 481.2 42 536.8 578.8 292 119.2 411.4 406
Net income 1 375 340 145 151 296 258 61.28 320 30 372 402 199 84.45 283.9 284
Net margin 16.59% 14.14% 13.09% 10.38% 11.55% 20.41% 6.32% 14.33% 3.92% 24.13% 17.42% 15.91% 8.47% 12.62% 23.18%
EPS 2 14.67 13.30 5.650 - - 10.10 - 12.49 1.160 - - 7.780 - 11.08 11.05
Dividend per Share 2.500 2.500 - - - - - 3.000 - - - - - 4.000 -
Announcement Date 13/08/20 12/08/21 11/11/21 09/02/22 09/02/22 12/05/22 09/08/22 09/08/22 10/11/22 13/02/23 13/02/23 11/05/23 09/08/23 09/08/23 13/11/23
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 811 1,907 2,101 2,151 2,413 2,693
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 218 1,260 240 399 252 430
ROE (net income / shareholders' equity) 14.9% 18.5% 14.5% 19.3% 19.1% 23.9%
ROA (Net income/ Total Assets) 11.5% 14.1% 11% 13.8% 13.5% 17.1%
Assets 1 3,457 3,534 3,927 4,619 5,353 6,181
Book Value Per Share 2 99.40 111.0 120.0 137.0 158.0 189.0
Cash Flow per Share 2 31.70 74.50 82.10 84.80 94.20 105.0
Capex 1 25 58 34 70 73 28
Capex / Sales 0.69% 1.35% 0.85% 1.41% 1.61% 0.54%
Announcement Date 28/03/19 30/03/20 29/03/21 30/03/22 29/03/23 28/03/24
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Software & Technology Services

1st Jan change Capi.
FINDEX INC. Stock FINDEX Inc.
-0.78% 168M
VEEVA SYSTEMS INC. Stock Veeva Systems Inc.
+6.15% 32.95B
PRO MEDICUS LIMITED Stock Pro Medicus Limited
+18.09% 7.82B
SECTRA AB Stock Sectra AB
+33.25% 4.17B
EVOLENT HEALTH, INC. Stock Evolent Health, Inc.
-26.25% 2.72B
LUNIT INC. Stock Lunit Inc.
-33.33% 1.15B
SIMULATIONS PLUS, INC. Stock Simulations Plus, Inc.
+13.27% 980M
B-SOFT CO.,LTD. Stock B-SOFT Co.,Ltd.
-37.56% 873M
VERADIGM INC. Stock Veradigm Inc.
-26.41% 831M
SURGICAL SCIENCE SWEDEN AB Stock Surgical Science Sweden AB
-15.51% 688M
Medical Software & Technology Services
  1. Stock Market
  2. Equities
  3. 3649 Stock
  4. Financials FINDEX Inc.